Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Horwich

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|March 7, 2006
Testicular germ-cell cancerAlan Horwich, Janet Shipley, Robert Huddart
BMJ (Clinical Research Ed.)|September 26, 2013
Testicular germ cell tumoursAlan Horwich, David Nicol, Robert Huddart
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Update on management of seminomaEmma J Alexander, Ingrid M White, Alan Horwich
Expert Review of Anticancer Therapy|February 10, 2012
Minimizing toxicity in early-stage testicular cancer treatmentMausam Singhera, Kathryn Lees, Robert Huddart, et al.
European Urology|June 24, 2009
Surveillance in stage I seminoma patients: a long-term assessmentSebastian Cummins, Thomas Yau, Robert Huddart, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2005
Site of relapse after chemotherapy alone for stage I and II Hodgkin's diseaseMehdi Shahidi, Nahid Kamangari, Sue Ashley, et al.
BJU International|March 1, 2013
Reply: Seminoma stage 1: Patterns of care in EuropeSusanne Osanto, Carla Vossen, Alan Horwich, et al.
Urology|October 12, 2011
Salvage therapy: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Alan Horwich, Gedske Daugaard, Christian Kollmannsberger, et al.
BJU International|March 14, 2012
Patterns of care in the management of seminoma stage I: results from a European surveyCarla Y Vossen, Alan Horwich, Gedske Daugaard, et al.
Clinical Lymphoma & Myeloma|September 4, 2008
Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II studyVedang Murthy, Karen Thomas, Kerwyn Foo, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|March 7, 2006
Testicular germ-cell cancerAlan Horwich, Janet Shipley, Robert Huddart
BMJ (Clinical Research Ed.)|September 26, 2013
Testicular germ cell tumoursAlan Horwich, David Nicol, Robert Huddart
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Update on management of seminomaEmma J Alexander, Ingrid M White, Alan Horwich
Expert Review of Anticancer Therapy|February 10, 2012
Minimizing toxicity in early-stage testicular cancer treatmentMausam Singhera, Kathryn Lees, Robert Huddart, et al.
European Urology|June 24, 2009
Surveillance in stage I seminoma patients: a long-term assessmentSebastian Cummins, Thomas Yau, Robert Huddart, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2005
Site of relapse after chemotherapy alone for stage I and II Hodgkin's diseaseMehdi Shahidi, Nahid Kamangari, Sue Ashley, et al.
BJU International|March 1, 2013
Reply: Seminoma stage 1: Patterns of care in EuropeSusanne Osanto, Carla Vossen, Alan Horwich, et al.
Urology|October 12, 2011
Salvage therapy: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Alan Horwich, Gedske Daugaard, Christian Kollmannsberger, et al.
BJU International|March 14, 2012
Patterns of care in the management of seminoma stage I: results from a European surveyCarla Y Vossen, Alan Horwich, Gedske Daugaard, et al.
Clinical Lymphoma & Myeloma|September 4, 2008
Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II studyVedang Murthy, Karen Thomas, Kerwyn Foo, et al.
Pageof 9